AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24150660 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen alone (48 mg·kg(‐1)·day(‐1))
Number of subjects: 152
Study 24150660 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen alone (24 mg·kg(‐1)·day(‐1))
Number of subjects: 152
Study 21341925 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 0-, 7-, 14-, or 21-mg doses
Number of subjects: 124
Study 21341925 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (independent of TN dose)
Number of subjects: 124
Study 21341925 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN)
Number of subjects: 124
Study 19236536 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth disinfection (FMD)
Number of subjects: 25
Study 19236536 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FM-SRP)
Number of subjects: 25
Study 19236536 — intervention group
Group type: COMPARATOR
Intervention: Quadrant scaling and root planing (Q-SRP)
Number of subjects: 25
Study 17297027 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil (Malarone)
Number of subjects: 0
Study 12737786 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable ultrasound device
Number of subjects: 211
Study 12737786 — intervention group
Group type: COMPARATOR
Intervention: Standard platform (gold standard)
Number of subjects: 211
Study 11188776 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG treatment (immunoglobulin 10% 1 g/kg bodyweight)
Number of subjects: 318
Study 11188776 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.1 g albumin/vial)
Number of subjects: 318
Study 11188776 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG treatment
Number of subjects: 318
Study 9538657 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 80 mg sotalol
Number of subjects: 34
Study 9538657 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 x 160 mg sotalol
Number of subjects: 34
Study 9538657 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of sotalol
Number of subjects: 34
Study 8404175 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline therapy
Number of subjects: 38
Study 8404175 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study 3096218 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-SP
Number of subjects: 58
Study 3096218 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-SP plus BH-AC
Number of subjects: 58
Study 30557747 — intervention group
Group type: EXPERIMENTAL
Intervention: Own-race stimuli
Number of subjects: 136
Study 30557747 — intervention group
Group type: COMPARATOR
Intervention: Other-race stimuli
Number of subjects: 136
Study 30557747 — intervention group
Group type: EXPERIMENTAL
Intervention: Associative training task with arbitrary visual stimuli
Number of subjects: 136
Study 28509584 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbow Flexed (EF) crutch setup
Number of subjects: 30
Study 28509584 — intervention group
Group type: COMPARATOR
Intervention: Elbow Straight (ES) crutch setup
Number of subjects: 30
Study 26227494 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm biofeedback training (DBT) + rabeprazole proton pump inhibitor (PPI)
Number of subjects: 40
Study 26227494 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole alone
Number of subjects: 40
Study 24745020 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive thoracic epidural analgesia (TEA) administered as a bolus before surgical incision and continued until the end of surgery.
Number of subjects: 44
Study 24745020 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive thoracic epidural analgesia (TEA)
Number of subjects: 44
Study 24745020 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative epidural analgesia
Number of subjects: 44
Study 22697440 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral treatments (CBT) for anxiety disorders, 12-week duration
Number of subjects: 87
Study 22697440 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive relaxation training program, 12-week duration
Number of subjects: 87
Study 18973896 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic oral contraceptive therapy (low-dose, monophasic OCP for 24 months)
Number of subjects: 239
Study 18973896 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oral contraceptive therapy (low-dose, monophasic OCP for 24 months)
Number of subjects: 239
Study 18973896 — intervention group
Group type: COMPARATOR
Intervention: No therapy (nonusers)
Number of subjects: 239
Study 18928120 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) of Sanyinjiao (SP 6), 2/100 Hz, 8‐10 mA, 3 times a week for 3 months
Number of subjects: 157
Study 18928120 — intervention group
Group type: COMPARATOR
Intervention: Medication group (oral nylestriol, 2 mg/time, twice a month for 3 months, with medroxyprogesterone from the third month)
Number of subjects: 157
Study 15970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric case management (exact details of dosage and duration not available)
Number of subjects: 0
Study 15970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of hospitalizations (only hospitalized patients included)
Number of subjects: 0
Study 15970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-state modeling approach (exact details of intervention not available)
Number of subjects: 0
Study 15970467 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional hazards regression (exact details of intervention not available)
Number of subjects: 0
Study 11879261 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 33
Study 11879261 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 100 mg
Number of subjects: 33
Study 11879261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 12490113 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acyclovir at 300 mg/day for 1 year (prophylaxis group)
Number of subjects: 105
Study 12490113 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 105
Study 9531028 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin, 120 IU/kg bw twice daily for 5-8 days and 7,500 IU once daily for 35-40 days
Number of subjects: 342
Study 9531028 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin, lower dose after initial high dose
Number of subjects: 342
Study 9531028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study 7973213 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy
Number of subjects: 0
Study 7973213 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 7973213 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 2691638 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 40
Study 2691638 — intervention group
Group type: COMPARATOR
Intervention: Tension inducement
Number of subjects: 40
Study 2691638 — intervention group
Group type: COMPARATOR
Intervention: Pre‐postcontrol
Number of subjects: 40
Study 2691638 — intervention group
Group type: COMPARATOR
Intervention: Postcontrol
Number of subjects: 40
Study 30869182 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice daily for 3 months
Number of subjects: 40
Study 30869182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29162572 — intervention group
Group type: EXPERIMENTAL
Intervention: Antistigma intervention consisting of staff training, raising awareness, a recovery-focused art programme, and analysis of internal policies and procedures.
Number of subjects: 6
Study 29162572 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 6
Study 26494108 — intervention group
Group type: EXPERIMENTAL
Intervention: Research‐based Developmentally Informed (REDI) Parent program (REDI‐P)
Number of subjects: 200
Study 26494108 — intervention group
Group type: COMPARATOR
Intervention: Mail‐home math games (comparison condition)
Number of subjects: 200
Study 23736109 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive medications (average of 1.7 medications)
Number of subjects: 3020
Study 21982138 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 46
Study 21982138 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment control
Number of subjects: 46
Study 18646481 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Heller myotomy with concomitant anterior fundoplication
Number of subjects: 353
Study 18646481 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Heller myotomy alone
Number of subjects: 353
Study 16574546 — intervention group
Group type: EXPERIMENTAL
Intervention: D3 surgery
Number of subjects: 221
Study 16574546 — intervention group
Group type: COMPARATOR
Intervention: D1 surgery
Number of subjects: 221
Study 12612295 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg + inhaled budesonide 800 microg/day
Number of subjects: 889
Study 12612295 — intervention group
Group type: COMPARATOR
Intervention: Double dose inhaled budesonide 1600 microg/day
Number of subjects: 889
Study 10832071 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ(10) supplementation (50 mg three times daily)
Number of subjects: 12
Study 10832071 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ(10) supplementation
Number of subjects: 12
Study 9103798 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush designed specifically for children
Number of subjects: 0
Study 9103798 — intervention group
Group type: COMPARATOR
Intervention: Children's manual toothbrush
Number of subjects: 0
Study 8194411 — intervention group
Group type: EXPERIMENTAL
Intervention: Sialography with the time-pressure curve monitored
Number of subjects: 66
Study 8194411 — intervention group
Group type: COMPARATOR
Intervention: Manual injection technique
Number of subjects: 66
Study 31838443 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT/Integrated
Number of subjects: 119
Study 31838443 — intervention group
Group type: COMPARATOR
Intervention: CBT/SUD
Number of subjects: 119
Study 31209657 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax in combination with Rituximab
Number of subjects: 182
Study 28359283 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated muscle training exercises concomitant to radiotherapy
Number of subjects: 60
Study 28359283 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation
Number of subjects: 60
Study 28359283 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated muscle training exercises
Number of subjects: 60
Study 25613938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (IVB) at 0.625 mg per eye per dose
Number of subjects: 24
Study 25613938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (IVB) at 0.25 mg per eye per dose
Number of subjects: 24
Study 25613938 — intervention group
Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 24
Study 23663798 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity program
Number of subjects: 273
Study 23663798 — intervention group
Group type: COMPARATOR
Intervention: Social support program
Number of subjects: 273
Study 23663798 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 273
Study 21807052 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg dose of parvovirus B19 recombinant capsid
Number of subjects: 43
Study 21807052 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 μg dose of recombinant capsid with MF59
Number of subjects: 43
Study 21807052 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg dose of recombinant capsid with MF59
Number of subjects: 43
Study 21807052 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 43
Study 19553184 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin tablets
Number of subjects: 7
Study 19553184 — intervention group
Group type: COMPARATOR
Intervention: Dissolution test as quality tool
Number of subjects: 7
Study 16715957 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordered subsets expectation maximization (OSEM)
Number of subjects: 14
Study 16715957 — intervention group
Group type: COMPARATOR
Intervention: Filtered backprojection (FBP)
Number of subjects: 14
Study 15744699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg once-daily subcutaneous regimen starting postoperatively
Number of subjects: 0
Study 15744699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux 4 weeks
Number of subjects: 0
Study 15744699 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study 15744699 — intervention group
Group type: COMPARATOR
Intervention: Fondaparinux 1 week
Number of subjects: 0
Study 11120907 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (1-100 microg/ml)
Number of subjects: 0
Study 11120907 — intervention group
Group type: COMPARATOR
Intervention: IL-8
Number of subjects: 0
Study 11120907 — intervention group
Group type: COMPARATOR
Intervention: f-Met-Leu-Phe (fMLP)
Number of subjects: 0
Study 9465382 — intervention group
Group type: EXPERIMENTAL
Intervention: Swanson Silastic spacer with titanium grommets (Gr. I)
Number of subjects: 250
Study 9465382 — intervention group
Group type: COMPARATOR
Intervention: Swanson Silastic spacer without titanium grommets (Gr. II and Gr. III)
Number of subjects: 250
Study 9465382 — intervention group
Group type: COMPARATOR
Intervention: Swanson Silastic spacer without titanium grommets (Gr. II)
Number of subjects: 250
Study 9465382 — intervention group
Group type: COMPARATOR
Intervention: Swanson Silastic spacer without titanium grommets (Gr. III)
Number of subjects: 250
Study 7934344 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathing in coastal waters (total immersion of the head)
Number of subjects: 1216
Study 7934344 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal streptococci concentration measured at chest depth
Number of subjects: 1216
Study 3791269 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (10 mg with breakfast and 5 mg with lunch for 3 days)
Number of subjects: 32
Study 3791269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 3791269 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 32
Study 29442148 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mg ticagrelor
Number of subjects: 14
Study 29442148 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg maintenance dose (MD)
Number of subjects: 14
Study 29442148 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical dosage regimen (180 mg LD, 90 mg MD)
Number of subjects: 14
Study 27138229 — intervention group
Group type: EXPERIMENTAL
Intervention: BTX‐A
Number of subjects: 30
Study 27138229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 27138229 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 25668998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine 0.5 μg/kg followed by epidural dexmedetomidine 0.5 μg/kg along with 5 ml; 0.25% ropivacaine
Number of subjects: 60
Study 25668998 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl 1 μg/kg followed by epidural fentanyl 1 μg/kg along with 5 ml; 0.25% ropivacaine
Number of subjects: 60
Study 24622263 — intervention group
Group type: EXPERIMENTAL
Intervention: daglutril (300 mg/day)
Number of subjects: 45
Study 24622263 — intervention group
Group type: EXPERIMENTAL
Intervention: daglutril
Number of subjects: 45
Study 20834187 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification program
Number of subjects: 54
Study 18589484 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC/3TC
Number of subjects: 0
Study 18589484 — intervention group
Group type: COMPARATOR
Intervention: TDF/FTC
Number of subjects: 0
Study 18589484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted PIs (FPV/r and LPV/r)
Number of subjects: 0
Study 18589484 — intervention group
Group type: EXPERIMENTAL
Intervention: DRV/r
Number of subjects: 0
Study 18589484 — intervention group
Group type: EXPERIMENTAL
Intervention: Etravirine, Raltegravir, Maraviroc
Number of subjects: 0
Study 16782685 — intervention group
Group type: EXPERIMENTAL
Intervention: Stuttering Treatment Research Evaluation and Assessment Tool (STREAT)
Number of subjects: 0
Study 14516239 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention (Web)
Number of subjects: 24
Study 14516239 — intervention group
Group type: COMPARATOR
Intervention: No Internet intervention (No-Web)
Number of subjects: 24
Study 10743799 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine sulfate (HCQ)
Number of subjects: 119
Study 10743799 — intervention group
Group type: COMPARATOR
Intervention: Placebo (delayed treatment)
Number of subjects: 119
Study 8692115 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic BMT
Number of subjects: 148
Study 8692115 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cytosine-arabinoside/daunorubicin (HDAC)
Number of subjects: 148
Study 8692115 — intervention group
Group type: COMPARATOR
Intervention: Autologous BMT
Number of subjects: 148
Study 8692115 — intervention group
Group type: EXPERIMENTAL
Intervention: HDAC (2 cycles)
Number of subjects: 148
Study 8692115 — intervention group
Group type: COMPARATOR
Intervention: HDAC (1 cycle)
Number of subjects: 148
Study 1741218 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric pulsatile pump
Number of subjects: 23
Study 1741218 — intervention group
Group type: COMPARATOR
Intervention: Other artificial pumping methods
Number of subjects: 23
Study 1741218 — intervention group
Group type: COMPARATOR
Intervention: Natural infant suckling
Number of subjects: 23
Study 1741218 — intervention group
Group type: COMPARATOR
Intervention: All methods (including artificial and natural)
Number of subjects: 23
Study 6385835 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical tobramycin and ticarcillin for 3 days
Number of subjects: 50
Study 6385835 — intervention group
Group type: COMPARATOR
Intervention: Empirical tobramycin and ticarcillin until afebrile and no longer granulocytopenic
Number of subjects: 50
Study 31369152 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide-based anesthetic (N2 O with propofol and remifentanil)
Number of subjects: 0
Study 31369152 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anesthesia (TIVA with propofol and remifentanil)
Number of subjects: 0
Study 30882355 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical virtual simulation (experimental group, n=21)
Number of subjects: 42
Study 30882355 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity simulator and realistic environment (control group, n=21)
Number of subjects: 42
Study 29237510 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior left pericardiotomy
Number of subjects: 350
Study 29237510 — intervention group
Group type: COMPARATOR
Intervention: Control group (no posterior left pericardiotomy)
Number of subjects: 350
Study 25454683 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) with home exercise
Number of subjects: 241
Study 25454683 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised plus home exercise
Number of subjects: 241
Study 25454683 — intervention group
Group type: COMPARATOR
Intervention: Home exercise alone
Number of subjects: 241
Study 24428802 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary behavior modification treatment (1.5 hours of individual counseling at study start, 1 hour at follow-up home visits after 6 weeks, support through cell phone text messages every two weeks, aimed to reduce dietary intake by 500 kcal/day)
Number of subjects: 68
Study 24428802 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 68
Study 22950829 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 acupressure device placed on the P6 acupressure point in Group A patients.
Number of subjects: 204
Study 22950829 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with inappropriate placement of device on the dorsal part of the carpus in Group B patients.
Number of subjects: 204
Study 19681413 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2.5 microg x kg(‐1)
Number of subjects: 90
Study 19681413 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microg x kg(‐1)
Number of subjects: 90
Study 19681413 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 90
Study 17718363 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse scale of image resolution (10 pixels per face)
Number of subjects: 0
Study 17718363 — intervention group
Group type: EXPERIMENTAL
Intervention: Finer scale of image resolution (17 pixels per face)
Number of subjects: 0
Study 17718363 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse scale of image resolution
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: 40K activity in females
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body potassium (TBK) in females
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: 40K activity in males
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body potassium (TBK) in males
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: Average TBK for males aged 20-49 years
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: Average potassium concentrations for males
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium concentrations
Number of subjects: 0
Study 15266079 — intervention group
Group type: EXPERIMENTAL
Intervention: Future work
Number of subjects: 0
Study 11124689 — intervention group
Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 4.7
Number of subjects: 20
Study 11124689 — intervention group
Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 6
Number of subjects: 20
Study 11124689 — intervention group
Group type: COMPARATOR
Intervention: Haemonetics MCS+
Number of subjects: 20
Study 11124689 — intervention group
Group type: EXPERIMENTAL
Intervention: All machines
Number of subjects: 20